Amyloid cardiomyopathy (cardiac amyloidosis) is a form of restrictive cardiomyopathy that can result in significant progressive diastolic congestive heart failure. As the name suggests, amyloid ...

Medications like donanemab (Kisunla) and lecanemab (Leqembi) target amyloid plaques that build up in the brain due to ...

At present, there is no known cure for amyloidosis ... undergo multiple blood tests, cardiac studies, bone marrow biopsy, lung studies, and CT or MRI studies to determine eligibility.

Vutrisiran can improve and maintain functional capacity and quality of life in patients with transthyretin amyloidosis with ...

People with transthyretin cardiac amyloidosis (ATTR-CA ... previously been observed in 8-16% of those referred for cardiac MRI or transcatheter aortic valve replacement for AS.

Vutrisiran improved all-cause mortality and recurrent CV independent of disease severity in cardiac amyloidosis. Regardless of cutoffs, vutrisiran also improved various health and quality of life ...

124 I-evuzamitide PET/MRI demonstrated 100% sensitivity and specificity in detecting cardiac amyloidosis. No false positive or false negative cases were observed. 124 I-evuzamitide PET/MRI ...